FTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation
- 1 February 2000
- journal article
- current awareness
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 21 (2) , 49-52
- https://doi.org/10.1016/s0165-6147(99)01419-4
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- FTY 720 SUPPRESSES IMMUNE RESPONSES BY MODULATING G-PROTEIN COUPLED RECEPTORS ON LYMPHOCYTES RESULTING IN ALTERED LYMPHOCYTE HOMINGTransplantation, 1999
- HUMAN PHARMACOKINETICS OF FTY 720Transplantation, 1999
- HUMAN SAFETY AND PHARMACOLOGY OF FTY 720Transplantation, 1999
- The identification of myriocin-binding proteinsChemistry & Biology, 1999
- Induction of Tolerance Toward Rat Cardiac Allografts by Treatment With Allochimeric Class I MHC Antigen And FTY7201Transplantation, 1997
- Immunosuppressive effect of a new drug, FTY720, on lymphocyte responses in vitro and cardiac allograft survival in ratsTransplant Immunology, 1996
- Immunosuppressants: Cellular and molecular mechanisms of actionAmerican Journal of Kidney Diseases, 1996
- 2-Substituted 2-aminoethanol: Minimum essential structure for immunosuppressive activity of ISP-I (Myriocin)Bioorganic & Medicinal Chemistry Letters, 1995
- Simple compounds, 2-alkyl-2-amino-1,3-propanediols have potent immunosuppressive activityBioorganic & Medicinal Chemistry Letters, 1995
- Design, synthesis, and structure-activity relationships of 2-substituted-2-amino-1,3-propanediols: Discovery of a novel immunosuppressant, FTY720Bioorganic & Medicinal Chemistry Letters, 1995